Back to top

GeneDx price target raised to $90 from $75 at Canaccord

Canaccord analyst Kyle Mikson raised the firm’s price target on GeneDx (WGS) to $90 from $75 and keeps a Buy rating on the shares. The firm said it...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GeneDx Holdings Corp. (WGS)